Maciej Banach

President of the International Lipid Expert Panel (ILEP); Head of European Program for Prevention (EPP), Adjunct Professor at the Johns Hopkins Medicine; EiC of the Archives of Medical Science, Deputy EiC of the EHJ Open

Łódź, Łódzkie, Poland

About

Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He was a President of Polish Mother's Memorial Hospital - Research Institute (PMMHRI) (February 2014-March 2021), He is Head of Cardiovascular Research Centre at University of Zielona Gora, full Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI, Head of Foreign Affairs Office (2012-2014), Head of Department of Hypertension (2008-) at the Medical University of Lodz and Professor in the Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, at the WAM University Hospital in Lodz, Poland (2009-). He is a Secretary of the European Atherosclerosis Society (EAS) (2021-2024) and member of the Scientific and Health Policy Advisory Group of the FH Europe. He is a Founder and Head of the Polish Lipid Association (PoLA) (2011-) and Lodz Chapter of Polish Society of Hypertension (2009-). He is the founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC; lbpmcgroup.umed.pl) Group (2012-) – a group of over 150 worldwide experts aimed to investigate the most important issues in the field of lipid disorders, hypertension, nutrition and cardiovascular risk, as well as the International Lipid Expert Panel (ILEP; ilep.eu) (2015-), currently with >50 national society members, which has been founded to prepare recommendations in the area of preventive cardiology in the most debatable issues that have not been covered in the existing guidelines. He is also a member of the REPROGRAM Consortium – a group of experts challenging with Covid-19 pandemic, member of 2 largest worldwide databases – the Global Burden of Disease (GDB) (University of Washington, Seattle, US) and Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC, Imperial College of London, UK). He is also Founder and President of the foundation – Think-Tank “Innovation for Health”, which gathers six main health research institutes and over 40 medical business representatives in Poland with main aim to make innovations in the medical area in Poland. Prof. Banach has published >1000 papers with combined IF >10,000 pts, number of citations: 26865 (acc. WoS-CC), 27,832 (SCOPUS), 32,121 (ResearchGate), and 41,563 (Google Scholar), Hirsch’s Index = 65 (WoS/Publons), 68 (SCOPUS), 75 (ResearchGate) and 83 (i10-index: 514) (Google Scholar) – being within 1% the highest cited scientists in the world according to ESI by Clarivate (with 40 TOP Papers).

Experience

  • Chief Medical Officer (CMO) at Graylight Imaging
    Sep 2024 - Present · 1 yr 10 mos

  • Visiting Senior Research Fellow at the Liverpool Centre for Cardiovascular Science (LCCS)
    Jan 2024 - Present · 2 yrs 6 mos

  • Adjunct Professor at The Johns Hopkins University School of Medicine
    Oct 2022 - Present · 3 yrs 9 mos

    Adjunct Professor at the Department of Medicine, Division of Cardiology, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, 600N Wolfe St, Carnegie 568, Baltimore, MD 21287, United States.

  • Chief Medical Officer (CMO) at Dairy Biotechnologies
    Sep 2022 - Present · 3 yrs 10 mos

  • Chief Medical Officer (CMO) at Nomi Biotech Corporation
    Jul 2021 - Present · 5 yrs